Immunotherapy News and Research

Latest Immunotherapy News and Research

Australian research unlocks new path for cancer immunotherapy

Australian research unlocks new path for cancer immunotherapy

Promising combination therapy could improve liver cancer outcomes

Promising combination therapy could improve liver cancer outcomes

Cardio-oncology experts highlight importance of heart health in cancer care

Cardio-oncology experts highlight importance of heart health in cancer care

Multi-omic profiling sheds light on chemo-immunotherapy resistance in lung cancer

Multi-omic profiling sheds light on chemo-immunotherapy resistance in lung cancer

New protein platform enhances cancer immunotherapy

New protein platform enhances cancer immunotherapy

PROSPECT-Lung trial aims to improve treatment for patients with resectable non-small cell lung cancer

PROSPECT-Lung trial aims to improve treatment for patients with resectable non-small cell lung cancer

Study pinpoints how a network of different proteins controls rest and activation

Study pinpoints how a network of different proteins controls rest and activation

Understanding how angiogenesis contributes to drug resistance in breast cancer

Understanding how angiogenesis contributes to drug resistance in breast cancer

TCR sequencing sheds light on tumor immune interactions in hepatocellular carcinoma

TCR sequencing sheds light on tumor immune interactions in hepatocellular carcinoma

Prostate cancer vaccines: Progress, challenges, and future directions

Prostate cancer vaccines: Progress, challenges, and future directions

High-dose chemotherapy followed by autologous stem cell transplant ineffective for patients with mantle cell lymphoma

High-dose chemotherapy followed by autologous stem cell transplant ineffective for patients with mantle cell lymphoma

New $1.4M grant supports innovative kidney cancer treatment strategy

New $1.4M grant supports innovative kidney cancer treatment strategy

First-in-class monoclonal antibody shows promise for rare, aggressive hyperinflammatory condition

First-in-class monoclonal antibody shows promise for rare, aggressive hyperinflammatory condition

Lab-grown tumor organoids predict patient response to CAR T cell therapy

Lab-grown tumor organoids predict patient response to CAR T cell therapy

New immunotherapeutic platform improves mRNA therapy efficacy against cancer

New immunotherapeutic platform improves mRNA therapy efficacy against cancer

Simple dietary supplement may provide new approach to boost CAR T cell cancer-fighting power

Simple dietary supplement may provide new approach to boost CAR T cell cancer-fighting power

Breakthrough treatment improves survival rates for children with B-ALL

Breakthrough treatment improves survival rates for children with B-ALL

Phase one trial explores novel immunotherapy for breast cancer

Phase one trial explores novel immunotherapy for breast cancer

EZH2 inhibitors enhance effectiveness of cancer immunotherapies

EZH2 inhibitors enhance effectiveness of cancer immunotherapies

Cancer cells block T-cell activation, but new therapies restore immune defenses

Cancer cells block T-cell activation, but new therapies restore immune defenses

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.